ITC's Tobacco Business at 11x Earnings: Kotak Institutional Equities Says the Market Has It Wrong

The Quick Take

• ITC's tobacco business trades at just 11x forward earnings per Kotak Institutional Equities, signaling potential undervaluation
• Kotak sees stronger growth ahead in ITC's non-tobacco businesses and believes a demerger could unlock significant value
• The Indian conglomerate's cigarette franchise generates durable cash flows that the current discount does not adequately reflect

Synthesized from 1 source — full coverage, sentiment breakdown, and forward signals below.

Kotak Institutional Equities has highlighted what it views as a significant mispricing in ITC's tobacco division, estimating the market values it at approximately 11x forward earnings—a meaningful discount to comparable consumer staples and tobacco franchises in domestic and international markets. The brokerage argues the market's persistent application of a conglomerate discount obscures the intrinsic value of the tobacco business, which generates predictable, high-margin cash flows and benefits from strong pricing power in India's predominantly cigarette-driven tobacco consumption market, one of the world's largest by volume.

Beyond tobacco, Kotak's analysis emphasizes stronger growth momentum in ITC's non-tobacco portfolio, which includes fast-growing FMCG brands, premium hotels, agribusiness operations, and paperboards and packaging divisions. The non-tobacco segments are growing faster than the core cigarette franchise and are increasingly valued on independent growth metrics. Kotak believes a potential structural separation of tobacco and non-tobacco operations could materially re-rate both businesses independently by allowing dedicated capital allocation and cleaner investor targeting, unlocking value that the conglomerate discount currently suppresses in ITC's share price.

The structural case for unlocking ITC shareholder value through a demerger has gained credibility as peer conglomerates globally have demonstrated that business separations can deliver sustained re-ratings. India's market has increasingly rewarded focused business models over diversified conglomerates, strengthening the strategic rationale for ITC's management to consider structural changes. Kotak's 11x forward earnings estimate on the tobacco segment provides a quantitative anchor suggesting that even a modest re-rating of the segment multiple could deliver significant value at the current ITC share price, making it a compelling value proposition for patient equity investors seeking undervalued Indian large-cap conglomerate exposure.